The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.

REMOGEN® OMEGA – The first microemulsion with Omega-3 fatty acids



REMOGEN® OMEGA is an innovative eye drop formulation with Omega-3 fatty acids indicated in case of ocular surface damage such as irritation, redness, burning, pain, dry eye, eye surgery, blepharitis, ocular fatigue and foreign body sensation. 



High protection, anytime, anywhere

VISMED®  GEL is a patented hypotonic formulation that contains both 0.30% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.

VISMED®  GEL MULTI is indicated in case of symptoms and signs of dry eye and/or ocular surface damage, due to diseases such as superficial keratitis, Sjögren syndrome or primary dry eye syndrome. For sustained lubrication of the eyes in case of sensation of dryness, burning and ocular fatigue and other minor complaints of no pathological significance induced, for example, by dust, smoke, dry heat, air conditioning, wind, cold, extended computer screen, contact lens wear (rigid or soft) or by ophthalmological screening methods. Its gel formulation makes it a high protective solution for patients post refractive surgery.

The innovative delivery system allows VISMED®  GEL MULTI to remain sterile and free from contamination for up to 3 months after opening. Its ergonomic and intuitive delivery system, 10 ml content and compact size design make it the perfect solution for a long lasting relief of more severe dry eye conditions.

Always at hand…high protection, anytime, anywhere


pdf VISMED® GEL MULTI leaflet
pdf VISMED® GEL MULTI dispenser video
trb_lock.gif Doctor information

  • English